What is the category of COVID-19 patients that require plasma therapy? Is there any category of patients who cannot undertake it, because of other health complications?
People who have moderate to severe illness are the right candidates for treatment through plasma therapy. Medically, I would say people who have pneumonia with type I respiratory failure and acute respiratory distress syndrome (ARDS) are the category of patients for this treatment. Patients with mild illness do not require plasma therapy and the treatment is futile in patients with very critical illness with multi-organ failure. There are no other medical conditions under which a patient cannot get this treatment.
How effective is the therapy?
Obviously, it is not a magic bullet and not 100% effective. It is one of the good treatment options available because as of now we do not have any definitive treatment for COVID-19. Most of the therapies are either experimental or have some effectiveness. This is one of the promising therapies, however, it is not an established treatment. More studies are needed to confirm its effectiveness but small studies have merged from the US- they are series of 5-patient report or 10-patient report.
In one series of 5-patient report, all 5 patients on ventilator have successfully come out of it and in another 10 series patients, they found the virus clearing happened rapidly after giving plasma treatment. Therefore, reports like these coupled with our first successful case where the patient responded well to the treatment indicate that plasma therapy is potentially effective therapy. However, larger studies need to be conducted to really say how effective it is.
How is the procedure conducted?
Denne historien er fra May 2020-utgaven av Healthcare Radius.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra May 2020-utgaven av Healthcare Radius.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Trigeminal neuralgia patient gains relief
Thumbnail-sized microvascular decompression gives relief to trigeminal neuralgia patient.
IMA forms national alliance to fight AMR
National Alliance of Medical Professionals on Antimicrobial Resistance formed
Abbott launches vertigo awareness campaign
Abbott’s new vertigo awareness campaign, Chakkar Ko Check Kar, aims to raise awareness about the condition that affects about seven-crore Indians.
HCG Cancer Centre hosts fitness challenge for doctors
HCG Cancer Centre Borivali and HCG ICS Khubchandani Cancer Centre, Colaba offer a fitness challenge for doctors on National Doctors’ Day.
IAP launches pediatric cough management awareness campaign
The Indian Academy of Pediatrics (IAP) kickstarts ‘Tackling Cough With Care’ initiative to spread awareness about pediatric cough management.
MedGenome invests in GenX Diagnostics lab
Expands presence in East India with stake acquisition
REVOLUTIONIZING THORACIC SURGERY WITH VATS
Explore how VATS is transforming thoracic surgery with precision, minimal trauma, and rapid recovery.
INTEGRATING AI INTO HEALTHCARE PRACTICES: A LEGAL PERSPECTIVE
Learn the legal challenges for AI adoption in healthcare: across medical devices, negligence, and data protection.
Godrej Consumer unveils breakthrough mosquito repellent
Indian scientists develop new molecule, Renofluthrin, to combat mosquito-borne diseases.
Narayana Health Insurance offers ₹1 cr coverage for surgeries
Narayana Health Insurance launches ‘ADITI’, a health insurance product offering coverage of up to ₹1 crore for surgeries and ₹5 lakh for medical management at Narayana Health.